Shopping Cart

Remove All

Your shopping cart is currently empty

Proceed to checkout Continue shopping

QC6352

Name: QC6352
Brand: TargetMol
SKU: T16700
Rating: 4.5 (1 reviews)

Copy Product Info

😃Good

Catalog No. T16700Cas No. 1851373-36-8

QC6352 is a selective and effective KDM4C inhibitor (IC50: 35 nM).

QC6352

Copy Product Info

😃Good

Catalog No. T16700Cas No. 1851373-36-8

QC6352 is a selective and effective KDM4C inhibitor (IC50: 35 nM).

Pack Size	Price	USA Warehouse	Global Warehouse
25 mg	$1,520	3-6 months	3-6 months
50 mg	$1,980	3-6 months	3-6 months
100 mg	$2,500	3-6 months	3-6 months
1 mL x 10 mM (in DMSO)	$434	3-6 months	3-6 months

Add to Cart

Add to Quotation

In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]

This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products.However, due to objective factors, there is a small probability that the synthesis may not be successful during the R&D process. We appreciate your understanding.If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Questions

Resource Download

Product Introduction

Bioactivity

Description	QC6352 is a selective and effective KDM4C inhibitor (IC50: 35 nM).
Targets&IC50	KDM4C:35 nM, KDM4B:56 nM, KDM4D:104 nM, KDM5B:750 nM, KDM4A:104 nM
In vitro	QC6352 is an effective KDM4C inhibitor (IC50: 35±8 nM). QC6352 blocks the proliferation and self-renewal of BCSCs. In a concentration-dependent manner QC6352 dramatically decreases the anchorage-independent sphere-forming capacity of BCSC1 and BCSC2. The protein levels of (Epidermal growth factor receptor) EGFR are reduced in both BCSC1 and BCSC2 upon treatment with QC6352 [1][2].
In vivo	QC6352 significantly inhibits tumor growth and final tumor weight in both BCSC1 and BCSC2 xenografts. The treatment is well tolerated, with no impact on mice body weight. Administration of the KDM4 inhibitor QC6352 effectively blocks BCSC xenograft tumor growth [2].

Chemical Properties

Molecular Weight	387.47
Formula	C₂₄H₂₅N₃O₂
Cas No.	1851373-36-8
Smiles	CN(c1ccccc1)c1ccc2[C@H](CNc3cnccc3C(O)=O)CCCc2c1
Relative Density.	1.243 g/cm3 (Predicted)

Storage & Solubility Information

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Solubility Information

DMSO: 25 mg/mL (64.52 mM), Sonication is recommended.

In Vivo Formulation

10% DMSO+40% PEG300+5% Tween-80+45% Saline: 1.5 mg/mL (3.87 mM), Sonication is recommended.

Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.

Solution Preparation Table

DMSO

	1mg	5mg	10mg	50mg
1 mM	2.5808 mL	12.9042 mL	25.8084 mL	129.0422 mL
5 mM	0.5162 mL	2.5808 mL	5.1617 mL	25.8084 mL
10 mM	0.2581 mL	1.2904 mL	2.5808 mL	12.9042 mL
20 mM	0.1290 mL	0.6452 mL	1.2904 mL	6.4521 mL
50 mM	0.0516 mL	0.2581 mL	0.5162 mL	2.5808 mL

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:

For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments

and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent

10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH₂O , the resulting working solution concentration would be 2 mg/mL.

Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSO TargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSO TargetMol | reagent stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH₂O TargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.

All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc